- $26.69bn
- $22.12bn
- $1.94bn
Moderna rises after UBS lifs PT on upcoming pipeline updates
U.S. STOCKS ON THE MOVE-Perella Weinberg Partners, Amkor Technology, Esperion Therapeutics
Moderna down after forecasting Q2 revenue below estimates
U.S. STOCKS ON THE MOVE-Paramount Skydance, Newell Brands, Rhythm,
U.S. STOCKS ON THE MOVE-Zetta Global, Church & Dwight
U.S. STOCKS ON THE MOVE-Reddit, Apple, Twilio
Moderna Q1 loss smaller than expected as COVID vaccine sales rise
Moderna tops revenue estimates on stronger international COVID vaccine sales (updated)
Moderna rises after first-quarter revenue beats estimates
Brief: Moderna Q1 EPS USD -3.4 Vs. IBES Estimate USD -3.96
Brief: Moderna Reports Q1 EPS Of $ -3.40
Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales
CureVac sues Moderna for patent infringement over COVID-19 vaccines
US CDC will not publish report showing COVID vaccine benefits, Washington Post reports (updated)
US CDC will not publish report showing COVID vaccine benefits, Washington Post reports
Moderna starts late-stage trial of bird flu vaccine in US, UK
Brief: Moderna Receives European Commission Marketing Authorization For mCOMBRIAX
Moderna wins EU approval for combined flu, COVID shot for older adults (updated)
Moderna wins EU approval for combined flu, COVID shot for older adults